• China Resources Pharmaceutical completes RMB 800 million third-tranche medium term notes issuance on Oct. 23, 2026.
• Wholly owned subsidiary China Resources Pharmaceutical Holdings issued the three-year notes at a 1.45% annual coupon.
• Net proceeds will repay interest-bearing debt and fund other purposes permitted under applicable laws and regulations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12381437), on October 23, 2026, and is solely responsible for the information contained therein.